EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of a prognostic two-lncRNA panel correlated with immune-associated transcripts for forecasting overall survival in pancreatic cancer

Hajar Eftekhari, Arash Safarzadeh, Emad Babakhanzadeh, Soudeh Ghafouri-Fard

Immunobiology · 2026

DOI: 10.1016/j.imbio.2026.153221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunobiology, 2026. Verfasst von Hajar Eftekhari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Pancreatic Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shahid Beheshti University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pancreatic cancer is among the most lethal cancers because of late diagnosis and inadequate therapeutic preferences. The tumor microenvironment and immune response have critical roles in disease progression and patient outcomes. LncRNAs are regulators of immune function and tumorigenesis, yet their prognostic value in pancreatic cancer remains partly clarified. METHODS: RNA-sequencing data and corresponding clinical features for 178 pancreatic cancer patients were obtained from TCGA. Immune-related mRNAs were retrieved from the MSigDB, and immune-related lncRNAs were identified based on a significant Pearson correlation with at least two immune-related mRNAs. Regression analyses were sequentially applied to construct a prognostic immune-related lncRNA set. The predictive performance of the set was assessed using time-dependent ROC curves and Kaplan-Meier survival analysis in both the TCGA training cohort and an independent external validation cohort (GSE224564). RESULTS: From 4059 lncRNAs, 1172 immune-related lncRNAs demonstrated strong associations with immune-related mRNAs. Sequential screening identified 34 survival-associated lncRNAs by univariate Cox regression (P < 0.01), 12 lncRNAs following LASSO regression, and ultimately two lncRNAs-CASC8 (HR = 1.7, P < 0.05) and LINC01004 (HR = 0.54, P < 0.05)-by multivariate Cox regression. A risk score signature was developed using these two lncRNAs. Time-dependent ROC analysis demonstrated moderate-to-good predictive precision in the training cohort, with area under the curve (AUC) values of 0.702, 0.774, and 0.84 for 1-, 3-, and 5-year overall survival, respectively. Patients in the high-risk group exhibited significantly worse survival compared to the low-risk group (P < 0.05). External validation in the GSE224564 cohort confirmed consistent risk stratification (P = 0.019), though with lower discriminative accuracy (AUC ∼ 0.60). Multivariate analysis demonstrated that the risk score acted as an independent prognostic factor in both cohorts. CONCLUSION: The CASC8 and LINC01004 immune-related lncRNA profile serves as a potential prognostic marker for pancreatic cancer. This set demonstrates increasing predictive trends over time in the training dataset. The presented findings offer novel insights into the correlation of immune-related lncRNAs with pancreatic cancer progression and provide a foundation for future risk stratification modeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingPancreatic NeoplasmsBiomarkers, TumorHumansPrognosisGene Expression Regulation, NeoplasticFemaleTumor MicroenvironmentMaleROC CurveGene Expression ProfilingKaplan-Meier EstimateRNA, MessengerMiddle Aged

Stichwörter der Autor:innen

BiomarkerCASC8Immune-related lncRNALINC01004Pancreatic cancerPrognosisTCGA

Substanzen

RNA, Long NoncodingBiomarkers, TumorRNA, Messenger

Autor:innen und Institutionen

  • Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: s.ghafourifard@sbmu.ac.ir.

Förderung

  • Shahid Beheshti University of Medical Sciences

Zitieren

APA

Eftekhari, H., Safarzadeh, A., Babakhanzadeh, E., & Ghafouri-Fard, S. (2026). Discovery of a prognostic two-lncRNA panel correlated with immune-associated transcripts for forecasting overall survival in pancreatic cancer. Immunobiology. https://doi.org/10.1016/j.imbio.2026.153221

Vancouver

Eftekhari H, Safarzadeh A, Babakhanzadeh E, Ghafouri-Fard S. Discovery of a prognostic two-lncRNA panel correlated with immune-associated transcripts for forecasting overall survival in pancreatic cancer. Immunobiology. 2026. doi:10.1016/j.imbio.2026.153221

BibTeX
@article{Eftekhari2026,
  author = {Eftekhari, Hajar and Safarzadeh, Arash and Babakhanzadeh, Emad and Ghafouri-Fard, Soudeh},
  title = {Discovery of a prognostic two-lncRNA panel correlated with immune-associated transcripts for forecasting overall survival in pancreatic cancer},
  journal = {Immunobiology},
  year = {2026},
  doi = {10.1016/j.imbio.2026.153221}
}
Kostenlos starten →